Selux Diagnostics focuses on antibiotic susceptibility testing (AST) to address the growing issue of antimicrobial resistance (AMR). The company provides healthcare providers, particularly hospitals, with rapid and comprehensive testing services that evaluate the effectiveness of various antibiotics against bacteria. This technology allows for simultaneous testing against all relevant antibiotics, which is a significant advancement in a field that has seen little innovation in recent years. By delivering faster diagnostic results, Selux helps ensure that patients receive the correct antibiotics, reducing the risk of ineffective prescriptions. The goal of Selux Diagnostics is to preserve the effectiveness of antibiotics for future generations and combat the global health crisis posed by AMR.